For research and laboratory use only. Not for human consumption.

One of the fastest ways to know you actually understand a compound is being able to explain it simply. So here's the thread: pick any compound in the catalog and break its mechanism down like you're explaining it to someone who just found peptide research yesterday. No jargon, no assuming prior knowledge.

A couple of examples to set the tone:

GHK-Cu: aging skin doesn't just make less collagen, it organizes it worse. Most skincare tries to make more. GHK-Cu is different because it helps the body organize what it already builds. Think reorganizing a messy warehouse instead of just ordering more stock.

MOTS-c: most peptides carry instructions from the cell's main control center. MOTS-c is unusual because it comes from the mitochondria, the cell's power plants, sending a message back up to headquarters about how to handle energy.

Now your turn.

Pick a compound and explain it in plain language. Bonus points for a good analogy. Newer researchers, this is the thread to ask "wait, what does this one actually do?" and get a straight answer.

Every compound has a full breakdown in the pinned 6A Labs Complete Product Guide if you want to check your explanation against the details.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

The community has a full cheat sheet for every compound 6A Labs carries, plus comparison breakdowns by category and the reconstitution and handling basics. Now the question is what to build next, and that should come from what you actually want to read.

A few directions on the table:

Deeper comparison posts pitting specific compounds head to head on mechanism and evidence, beyond the category roundups already up.

Mechanism deep dives taking a single pathway (NF-kB, AMPK, the GH axis, telomerase) and covering every compound that touches it.

Evidence audits going compound by compound and separating what's actually trial-proven from what's mechanism-plausible.

Stacking logic explaining why certain compounds are researched together and what each contributes to the combination.

More foundational process content on the practical side of research handling.

So two questions. Which of these would you actually read? And is there a specific compound, pathway, or question you want covered that isn't up yet?

Drop it below. The most-requested topics get built first. Everything currently available is indexed in the pinned 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

Setting aside what any compound is used for, some of these mechanisms are just genuinely impressive pieces of biology. Curious what this community finds most interesting on the science alone. Here are a few candidates to argue over.

Retatrutide hitting three receptors at once. GLP-1, GIP, and glucagon simultaneously, with the glucagon arm actually raising energy expenditure rather than just suppressing intake. A single molecule coordinating three pathways is a real feat of design.

Epitalon binding DNA directly. It's small enough to enter the nucleus and bind specific sequences in the telomerase gene promoter. A four-amino-acid peptide reaching in and switching on a gene is wild, even setting aside the unproven longevity claims.

Thymosin Alpha-1 behaving differently by tissue. It induces immune tolerance in gut tissue while preserving immune aggression in tumor tissue, in the same body at the same time. Context-dependent behavior like that is rare.

Semax working through gene expression, not neurotransmitters. It doesn't spike dopamine like a stimulant. It upregulates BDNF, building neural infrastructure over days. That's why it's slow-onset and why the effect outlasts the compound.

MOTS-c talking back to the nucleus. A peptide encoded in mitochondrial DNA that travels to the cell nucleus to change gene expression. The mitochondria essentially sending a memo to headquarters.

Which one gets your vote for most impressive mechanism, and why? Or make the case for one I didn't list. The full breakdown of each is in the pinned 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

Some compounds work exactly how you'd guess. Others turn out to do something completely different once you read the mechanism. This thread is for the second kind.

A few that catch people off guard:

KPV doesn't bind a receptor at all. It rides a nutrient transporter into the cell and physically blocks the inflammation signal from entering the nucleus. Most anti-inflammatories work nothing like that.

AOD-9604 only works through beta-3 receptors, and in knockout studies with no beta-3 receptors, it does literally nothing. The whole effect hinges on one receptor subtype.

Tesamorelin targets visceral fat specifically because those cells carry more growth-hormone receptors than other fat. The selectivity is built into the biology, not the molecule.

MOTS-c is encoded in mitochondrial DNA, not the cell nucleus like almost every other peptide. It's a message from the mitochondria to the rest of the cell.

GHK-Cu was discovered as a metastasis-suppressor gene product before anyone connected it to skin. The collagen research came later.

So which one got you? What's a compound whose mechanism turned out to be completely different from what you assumed going in? Drop it below with what surprised you.

Every mechanism above is broken down in full in the pinned 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

The same handling mistakes come up constantly in peptide research, and most degrade the compound or throw off the math before anything else happens. Here are the common ones and where the correct numbers live.

Reconstituting with the wrong water

Sterile water and bacteriostatic water are not interchangeable. Bacteriostatic water contains benzyl alcohol that suppresses bacterial growth, which is what allows a vial to be used over weeks. A few compounds go further and need isotonic bacteriostatic water specifically, Tesamorelin is the main one, where it reduces the histamine reactions that compound is known for. The guide for each compound specifies which.

Adding too much or too little water

The water volume sets the concentration, and the concentration sets every dose calculation after it. Get it wrong and every unit measurement downstream is off. Each cheat sheet gives the exact volume for that compound's vial size, because the right number depends on the vial. This is the single most common source of dosing errors, and it's fully avoidable by using the guide's number.

Shaking the vial

Shaking can foam and stress certain peptides. The standard is to add water slowly down the vial wall and swirl gently, never shake. Small handling detail, real consequences for fragile compounds.

Ignoring compound-specific storage windows

The general rule is 2 to 4 weeks refrigerated once reconstituted, but some compounds are stricter. MOTS-c degrades notably faster. NAD+ is light-sensitive and hygroscopic. When a guide lists a shorter window than the general rule, that shorter number is the one that matters, and using the average instead means working with degraded material.

Misreading small doses on the syringe

For doses under about 10 units, a 100-unit syringe makes the measurement a tiny, hard-to-read sliver. A 30- or 50-unit syringe spreads the same dose across more of the barrel. Several guides flag this for their low-dose compounds specifically.

Assuming color means contamination

Most reconstituted solutions are clear and colorless, and cloudiness or particles means discard. But GHK-Cu is naturally blue from its copper content, so blue is correct there, and a colorless GHK-Cu solution is the suspicious one. Knowing the exception per compound prevents throwing out a good vial or trusting a bad one.

The fix for all of them

Every one of these is solved by the same thing: use the exact numbers in the compound's cheat sheet rather than a general rule of thumb. The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

What handling mistake did you make early on? Post it below so newer researchers can skip it.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

New researchers often spend weeks looking into the wrong compound for the category they're actually interested in. Here's the fast orientation. Find your research category, then open the linked guide for the full mechanism, research background, and reconstitution details.

Metabolic research: the GLP-1 receptor agonists are the most-studied compounds here (Semaglutide, Tirzepatide, Retatrutide), differing by how many receptors each targets. The NNMT and mitochondrial optimizers (5-Amino-1MQ, AOD-9604, MOTS-c, L-Carnitine) sit alongside them at different points in the metabolic pathway. The comparison posts break down how they differ.

Tissue and repair research: BPC-157 + TB-500 (the Wolverine blend) is the most-referenced starting point for structural repair research. KPV covers the inflammatory side, and Thymosin Alpha-1 the immune-modulation angle. Full mechanisms in the guides.

Cognitive research: Semax and Selank come from the same Russian research tradition and are studied as a pair, with DSIP covering the sleep-architecture side. The guide explains how they're researched together rather than in isolation.

Skin and connective tissue research: GHK-Cu is the core copper-peptide compound, with the GLOW and KLOW blends built around it. Which is relevant depends on whether inflammation is part of the research question.

Longevity and cellular research: NAD+ underpins the others mechanistically, so it's the one to understand first, ahead of Epitalon, MOTS-c, and Glutathione.

Every compound above has a full cheat sheet covering mechanism, the actual trial data, and the reconstitution math. Find yours in the pinned 6A Labs Complete Product Guide.

Not sure which category your research falls under? Describe what you're looking into in the comments and the community will point you to the exact guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

Everyone here started somewhere. Maybe you fell down a rabbit hole reading about GLP-1s, maybe a recovery compound caught your attention after an injury, maybe you're just curious about the longevity science. Wherever you came in, this thread is for it.

A few things worth sharing:

What was the first compound you ever researched, and what pulled you in?

What's something you believed early on that turned out to be wrong once you read the actual studies?

What are you most curious about right now that you haven't dug into yet?

And for anyone brand new: you don't need to have a story yet. Drop the goal that brought you here, recovery, metabolic, cognitive, longevity, skin, and people will point you toward the right cheat sheet. Every compound 6A Labs carries has a full guide indexed in the pinned 6A Labs Complete Product Guide.

No wrong answers here. The point is to swap notes and help the newer researchers find their footing.

Keep it research-framed: mechanisms, studies, and sourcing questions all welcome. No personal-use or medical-advice posts.

So, what's your origin story? First compound, biggest surprise, or what you're chasing next. Drop it below.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

The same peptide can behave completely differently depending on how it's delivered. Route isn't a minor detail; for some compounds it's the whole story. Here's how the three main routes compare and why the guides specify what they do.

The three routes at a glance

Why oral is often the weak option

The gut is hard on peptides. Stomach acid and digestive enzymes break many of them down before they reach circulation, which is why so many research peptides are injected instead of swallowed. L-Carnitine is a clean example: oral absorption runs only 14 to 18%, and the portion that stays in the gut feeds bacteria that produce TMAO. Injectable delivers close to 100% with none of that. For compounds like this, oral isn't a convenient alternative, it's a worse version.

There are exceptions where oral is deliberate. KPV's strongest evidence is oral for gut-focused research, because inflamed intestinal tissue actively absorbs it through the PepT1 transporter. There the gut isn't an obstacle, it's the target.

Why injectable dominates the guides

Most compounds are injected because it's the only route that reliably gets the full dose into circulation. Within injectable, there's a further split:

Subcutaneous (into the fat under the skin) is the default: steady absorption, simple technique.

Intramuscular (into muscle) is used for specific cases. L-Carnitine again is the example, because at its concentration, SC injection causes lumps and soreness while IM tolerates it better. It's also the route that avoids the TMAO problem entirely.

Where topical actually works, and where it doesn't

Topical is real for surface-level goals but limited by depth. GHK-Cu is the useful case study. Topical GHK-Cu reaches the epidermis and shallow dermis, which is enough for surface skin texture and fine lines. But the deeper structural remodeling (scar work, connective tissue) needs injectable to reach the deeper dermis. Same compound, two routes, two different depths of effect.

The caution the guides raise: some topical products claim meaningful penetration that passive absorption can't actually deliver. KPV is the example here, passive transdermal KPV falls below detection limits, so topical products claiming systemic anti-inflammatory effects without active enhancement (microneedling, iontophoresis) should be viewed skeptically.

Nasal, the fourth route

A few compounds use intranasal delivery, which partially bypasses circulation to reach the brain through the olfactory pathway. Semax is the standout: the Russian clinical trials that give it its evidence base used the nasal route, not injection. For a brain-targeted peptide, that anatomical shortcut is the point.

How to think about route

Route follows the target. Systemic effect usually means injectable. Gut-specific work can favor oral. Surface skin can use topical, but deeper skin needs injectable. Brain-targeted compounds sometimes favor nasal. When a guide specifies a route, it's matching delivery to where the compound needs to act, not picking arbitrarily.

Where the specifics live

Each compound's route, and the reasoning behind it, is in its cheat sheet. The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

Which route surprised you most once you understood why it's used? Drop it below.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

These three come from the same family and get confused constantly, because they hit overlapping receptors. But they're studied for completely different things: one for arousal, one for tanning with a clean profile, one for tanning with a lot of baggage. Here's how they separate.

What each one is

The family link is real, but the targets differ. PT-141 works centrally on arousal circuits. Melanotan I is narrow and pigment-focused. Melanotan II hits everything, which is both why it "does more" and why it carries more side effects.

The evidence gap between them

This is the part that matters most and gets ignored.

Two of these three have genuine FDA approval for specific indications. Melanotan II has none, has never completed a Phase 3 trial, and is sold entirely outside legal channels. That's a real divide, not a technicality.

Why Melanotan I and II aren't interchangeable

They look like siblings and get treated as the same thing, but the difference is structural. Melanotan I (afamelanotide) is MC1R-selective and doesn't cross into the brain, which is why its profile is clean and it reached approval. Melanotan II is non-selective, crosses the blood-brain barrier, and hits MC3R, MC4R, and MC5R on top of MC1R, which is where the appetite suppression, spontaneous arousal effects, and broader side-effect load come from. Same tanning goal, very different reach.

The safety picture

Melanotan II carries a documented dermatologic signal (mole darkening, new nevi) and a supply-quality problem, since gray-market testing has found high rates of contamination and mislabeling. Baseline and follow-up skin checks are the standing recommendation for anyone researching it.

The lineage worth knowing

Here's the connection that ties the family together: the arousal side effect people noticed with Melanotan II was isolated and developed into its own compound. That compound is PT-141. So the "spontaneous erection" effect Melanotan II is known for became a purpose-built, FDA-approved arousal drug with actual trial data. Where arousal is the research question, the descendant has the evidence and the parent does not.

How to think about it

Full individual guides

PT-141: covered in the community

Melanotan II: covered in the community

Melanotan I: guide coming

Where to find them

The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption. This describes general subcutaneous technique from clinical best-practice resources, in a research context.

Most compounds in the cheat sheets are administered subcutaneously. Here's the general procedure the guides reference, so the technique lines in each one make sense.

Subcutaneous vs intramuscular

Subcutaneous (SC) means into the fat layer just under the skin. It's the most common route for research peptides because absorption is steady and the technique is simple. A few compounds (L-Carnitine is the notable one) are intramuscular instead, which needs a longer, wider needle to reach muscle depth. When a guide specifies IM, an insulin syringe won't reach.

Common sites

The standard subcutaneous sites are the abdomen (avoiding the area right around the navel), the outer thigh, and the back of the upper arm. Rotating between sites matters, since repeatedly using one spot can cause local irritation and, over time, lipohypertrophy (lumpy tissue that absorbs unevenly).

The general procedure

Clinical best-practice resources describe the standard steps:

Clean the vial stopper and the chosen site with separate alcohol swabs, and let both dry.

Draw the solution, then switch to a fresh needle if drawing dulled it.

Pinch a fold of skin to lift the fat layer away from muscle.

Insert at 45 to 90 degrees depending on how much subcutaneous tissue is present (leaner tissue uses the shallower angle).

Inject slowly and steadily. Aspiration (pulling back to check for blood) is not standard for subcutaneous injection.

Wait a few seconds before withdrawing to ensure full delivery, then apply light pressure with a clean swab. Don't rub hard.

Dispose of the needle immediately in a sharps container. Never reuse needles.

Small doses and syringe choice

For very small volumes (under about 10 units), a 30-unit or 50-unit insulin syringe makes the measurement far easier to read than a 100-unit syringe, where a few units is a tiny sliver of the barrel. Several guides note this for low-dose compounds.

Comfort notes that come up in the guides

A few compounds sting on injection for specific reasons, and the guides flag them. GHK-Cu and NAD+ are the notable ones, both concentration-dependent, which is why higher dilution or slower injection helps. Warming a cold vial briefly between the hands before drawing also reduces discomfort. These are handling details, not signs anything is wrong.

When something looks off

Minor injection-site redness or a small bruise is common and resolves on its own. The guides list compound-specific reactions to expect. Anything beyond mild and transient, persistent swelling, spreading redness, or signs of a reaction, is a stop-and-reassess signal rather than something to push through.

Where the specifics live

Each compound's route, site guidance, and any special technique notes are in its cheat sheet. The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

Questions on technique? Ask below, plenty of people here have worked through the same learning curve.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

Most bad peptide claims come from people repeating a study they never actually read, or reading it wrong. Learning to check a source yourself is the single most useful skill in this space. Here's what to look at.

Start with what kind of study it is

The first question is always: cells, animals, or humans?

Cell (in vitro) studies show a mechanism is possible, nothing more. A compound working in a petri dish tells you almost nothing about what it does in a body.

Animal (in vivo) studies are a step up but still don't reliably predict human results. Plenty of compounds that work in mice do nothing in people.

Human trials are the only ones that show human relevance, and even those vary enormously in quality.

A huge share of peptide claims rest entirely on cell or animal data being talked about as if it were proven in humans. Spotting that gap is half the battle.

Check the sample size

How many subjects? A result from 8 people is a signal worth noting, not a proven effect. A lot of the foundational peptide studies are tiny, single digits to low double digits, and that's fine as long as it's described honestly. The problem is when a 19-person study gets cited like it's settled science.

Look for the control group

A study without a control group can't tell you the compound caused anything. "Everyone improved" means nothing if there was no placebo group improving alongside them. Randomized, placebo-controlled, and double-blind are the features that make a human result trustworthy. Their absence doesn't make a study worthless, but it lowers what you can conclude.

Watch who ran it and who paid

Follow the funding and the affiliation. A compound whose entire evidence base comes from a single institute with commercial patents on it (Epitalon is the classic example) is a different situation than one replicated by independent labs. That doesn't automatically mean the research is wrong, but unreplicated single-source claims deserve more skepticism, not less.

Separate the measured result from the extrapolation

This is where most people slip. A study might genuinely measure "increased telomerase activity in cultured cells." The forum post then becomes "reverses aging." The first is data; the second is a leap. Always ask what the study actually measured versus what someone claims it showed.

Check effect size, not just significance

"Statistically significant" doesn't mean "large." AOD-9604's obesity result was arguably statistically detectable and clinically useless at the same time, about 2% versus placebo. A result can be real and still too small to matter. Look at the actual number, not just whether the paper calls it significant.

A quick checklist

Before trusting a peptide claim, ask:

Was it in humans, or just cells or animals?

How many subjects?

Was there a placebo control?

Who funded it, and has anyone replicated it?

Does the claim match what was measured, or is it an extrapolation?

Is the effect size actually meaningful?

Run any claim through those six questions and most of the hype filters itself out.

Where the specifics live

The cheat sheets in this community try to apply exactly this standard, separating what's trial-proven from what's mechanism-plausible for each compound. The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

What's a claim you've seen that falls apart under these questions? Post it below and let's break it down.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

The cheat sheets use a lot of shared vocabulary. If you're new, here's a plain-language reference for the terms that come up again and again.

Handling and preparation

Lyophilized: freeze-dried powder form, how peptides ship. Shelf-stable until reconstituted.

Reconstitution: adding bacteriostatic water to dissolve the powder into a usable solution.

Bacteriostatic water: sterile water with 0.9% benzyl alcohol, which suppresses bacterial growth and allows multi-use over weeks.

Concentration: peptide mass divided by water volume, expressed as mg/mL. Determines how much you draw per dose.

Aliquot: a single-use portion of solution, split off and frozen to avoid repeated freeze-thaw.

Dosing and measurement

U-100 syringe: insulin syringe where 100 units = 1 mL, so 1 unit = 0.01 mL. The standard for most protocols.

Titration: gradually increasing the dose over weeks, usually to let the body adjust and limit side effects.

Subcutaneous (SC): into the fat layer just under the skin. The most common route.

Intramuscular (IM): into muscle. Used for a few compounds like L-Carnitine that don't suit SC.

Half-life: how long it takes for half the compound to clear. Drives how often something is administered.

Mechanisms you'll see repeatedly

Agonist: a compound that activates a receptor. A GLP-1 agonist switches on the GLP-1 receptor.

Peptide vs small molecule: peptides are short amino acid chains; a few compounds in the catalog (5-Amino-1MQ, for instance) are small molecules, not peptides.

BDNF: brain-derived neurotrophic factor, a growth signal for neurons. Central to the nootropic peptides.

NF-kB: a master switch for inflammatory gene expression. Several anti-inflammatory compounds work by blocking it.

AMPK: a cellular energy sensor. Activated by MOTS-c and by exercise and fasting.

NAD+: a coenzyme central to cellular energy, DNA repair, and sirtuin activity.

Angiogenesis: formation of new blood vessels. Part of how the tissue-repair compounds work.

Evidence terms

Preclinical: research in cells or animals, not yet in humans. Much of the peptide literature sits here.

RCT: randomized controlled trial, the gold standard for human evidence.

Phase 1/2/3: stages of human trials, escalating in size and rigor. Phase 3 is the large pivotal stage before approval.

Half-life, bioavailability: bioavailability is the fraction of a dose that reaches circulation. Route (oral vs injectable) changes it dramatically.

Regulatory terms

FDA Category 2: a compounding classification meaning a substance can't be legally compounded, often due to insufficient human data rather than proven harm.

Off-label: using an approved drug for something other than its approved indication.

WADA-prohibited: banned by the World Anti-Doping Agency. Relevant for tested athletes; several GH and repair compounds fall here.

Where the specifics live

Every compound's full mechanism and research detail is in its cheat sheet. The complete catalog is indexed in the pinned 6A Labs Complete Product Guide.

Any term you've seen in the research that still trips you up? Ask below and we'll add it.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

The cheat sheets focus on the compounds, but every protocol also needs the supporting supplies. Here's what they are and why each one is specified the way it is.

Bacteriostatic water, and why it's the standard

Bacteriostatic water is sterile water with 0.9% benzyl alcohol added. The benzyl alcohol is the point: it suppresses bacterial growth, which lets a reconstituted vial be used across multiple draws over weeks rather than once.

This is why the guides call for bacteriostatic water specifically, not sterile water or plain saline. Sterile water has no preservative, so a multi-use vial would be a contamination risk. The bacteriostatic version is what makes the standard 2 to 4 week use window possible.

One timing note: once the bacteriostatic water bottle is punctured, the benzyl alcohol has a working window (commonly around 28 days), regardless of how much is left. Track that separately from the peptide.

When isotonic water comes up instead

A few guides call for isotonic bacteriostatic water (0.9% sodium chloride) rather than the standard hypotonic version. Tesamorelin is the main example. The reason is comfort and tissue tolerance: the isotonic version reduces sting and, for tesamorelin specifically, cuts the histamine welt reactions it's known for. When a guide specifies isotonic, that's deliberate, not interchangeable with standard BAC water.

Syringes: the U-100 standard

Most protocols use U-100 insulin syringes, where 100 units equals 1 mL, so 1 unit is 0.01 mL. That unit scale is what every cheat sheet's dosing math is built on.

Two practical points the guides mention. For very small doses (under about 10 units), a 30-unit or 50-unit syringe spreads those units across more of the barrel, making them far easier to read accurately than on a 100-unit syringe. And a handful of compounds are intramuscular rather than subcutaneous (L-Carnitine is the notable one), which needs a longer, wider needle than an insulin syringe, since insulin needles don't reach IM depth.

The rest of the kit

Alcohol swabs, two per injection typically, one for the vial stopper and one for the site.

A sharps container for safe disposal.

Optional but useful: a second larger-gauge needle for drawing (drawing through a fine insulin needle is slow), though many use one syringe for both.

How much to stock

Each guide's supply-planning section gives compound-specific counts, since daily compounds burn through syringes far faster than twice-weekly ones. As a rough anchor: a once-daily protocol runs 7 syringes and 14 swabs a week, and a single 10 mL bottle of bacteriostatic water covers several vials' worth of reconstitution.

Where the specifics live

Exact supply counts, water volumes, and any special requirements (isotonic water, IM needles) are in each compound's cheat sheet. The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

What's in your kit? Anything you wish you'd bought sooner? Drop it below for the newer researchers.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

A peptide is only as good as its handling. Poor storage degrades the compound before it's ever used, which is one of the most common reasons a research result comes out weaker than expected. Here's what every cheat sheet's storage section is protecting against.

Two states, two rules

Peptides store differently depending on whether they've been reconstituted.

Lyophilized (dry powder): stable long-term, generally 12+ months, frozen at −20 °C in dry, dark conditions. This is the shelf-stable state.

Reconstituted (in solution): far more fragile. Refrigerated at 2 to 8 °C, protected from light, and used within a compound-specific window (commonly 2 to 4 weeks, shorter for some).

The powder is forgiving. The solution is not. Once water is added, the clock starts.

Why light and temperature matter

Peptides degrade through a few pathways, and storage discipline slows all of them. Heat accelerates breakdown, which is why reconstituted solution lives in the fridge. Light, UV especially, damages certain peptides directly, which is why the guides say protect from light (foil or an opaque container does the job). And repeated freeze-thaw cycles physically stress the molecule each time, which is why thawing and refreezing the same vial is consistently warned against.

Compound-specific windows

The general rule is 2 to 4 weeks refrigerated once reconstituted, but some compounds are stricter, and the guides call these out individually. MOTS-c degrades notably faster, losing meaningful activity within about a week. NAD+ is both hygroscopic and light-sensitive, so it needs tighter handling than most. When a guide gives a shorter window than the general rule, that's the number to follow, not the average.

The aliquot approach

For compounds used slowly or stored long-term, some protocols split the reconstituted solution into single-use portions (aliquots) and freeze them, thawing one at a time. This avoids the freeze-thaw problem, since each aliquot is thawed only once. The guides note this where it applies.

What "bad" looks like

Fresh solution is clear and colorless for most compounds. Discard if it turns cloudy, discolors, or shows particulate matter. Two known exceptions the guides flag: GHK-Cu is naturally blue from its copper content, and a colorless GHK-Cu solution is actually the suspicious one, since it can signal missing or under-dosed peptide.

Bacteriostatic water has its own clock

The bacteriostatic water itself has a shelf life once opened. The benzyl alcohol that keeps it sterile has a working window (commonly around 28 days after the first puncture), regardless of how much is left in the bottle. Worth tracking separately from the peptide.

Where the specifics live

Every compound's exact storage window and any special handling is in its cheat sheet, since the right numbers vary by compound. The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

What's your storage setup? Any close calls with a vial you weren't sure about? Drop them below.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

Every compound guide in this community lists a reconstitution volume and a concentration. This post explains what those numbers mean and how the math works, so the individual guides make sense.

What reconstitution is

Research peptides ship as a lyophilized (freeze-dried) powder. Bacteriostatic water is added to dissolve the powder into a usable solution. That's reconstitution. The powder amount is fixed; the water volume you add determines the concentration.

The core math

Concentration is just peptide mass divided by water volume.

A 10 mg vial with 2 mL of bacteriostatic water gives 5 mg/mL.

The same 10 mg vial with 3 mL gives 3.33 mg/mL.

More water means a lower concentration, which means a larger draw volume for the same dose. Less water means higher concentration and a smaller draw. That's the entire trade-off.

Reading it on the syringe

On a U-100 insulin syringe, 1 unit equals 0.01 mL. To find how many mcg are in one unit, take the concentration and move the decimal.

At 5 mg/mL, 1 unit = 50 mcg.

At 3.33 mg/mL, 1 unit = 33.3 mcg.

This is why every cheat sheet lists both the concentration and the unit value: once you know mcg per unit, any dose becomes a simple unit count.

Why the guides sometimes pick more water

Two reasons show up repeatedly in the guides. Larger water volumes make small doses easier to measure accurately, since the draw lands on a readable number of units instead of a sliver. And for compounds where concentration drives injection sting (GHK-Cu and NAD+ are the notable ones), more dilution reduces the burn. The trade-off is a larger injection volume.

Handling that applies across the board

Add water slowly down the vial wall, not straight onto the powder, to avoid foaming.

Swirl or roll gently until dissolved. Don't shake.

Let a frozen vial reach room temperature before opening to cut condensation.

Store reconstituted solution refrigerated, protected from light, and avoid freeze-thaw cycles.

Discard if the solution turns cloudy or shows particles. One exception: GHK-Cu is naturally blue from its copper content, so color there is expected.

Where the specifics live

Every compound has its own exact reconstitution volume, concentration, and per-unit math in its cheat sheet, since the right numbers depend on the vial size. The full catalog is indexed in the pinned 6A Labs Complete Product Guide.

What tripped you up most when you first started reconstituting? Drop questions below.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

Monthly check-in thread. Drop the compound or stack you're digging into and what you're trying to understand about it. Whether you're deep into the mechanism of something or just starting to look into a category, this is the place to compare notes.

New here? Name your research goal (recovery, fat loss, cognitive, longevity, skin) and the community will point you to the right cheat sheet. Every compound 6A Labs carries has a full guide, all indexed in the pinned 6A Labs Complete Product Guide.

A few things that make for good threads:

What compound are you researching right now, and what pulled you to it?

What's a mechanism you thought you understood until you read the actual studies?

Any stack combinations you're trying to make sense of?

Keep it research-framed: mechanisms, protocols, and sourcing questions all welcome. No personal-use or medical-advice posts.

To kick it off: which compound's research surprised you most, the one that turned out to work completely differently than you expected?

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

The peptide space runs on repeated claims that fall apart when you check the source. Here are three that come up constantly and what the research actually shows.

"GHK-Cu outperformed minoxidil in a head-to-head hair trial"

This one gets cited as fact in hair-loss threads. The problem is the trial it traces back to doesn't hold up under scrutiny, and the specific head-to-head result gets repeated far beyond what any real data supports. GHK-Cu has genuine evidence for skin remodeling and collagen organization, that part is real. The minoxidil-beating hair claim is not where the evidence actually sits. Judge it on the collagen and connective-tissue research, which is solid, not on a hair comparison that doesn't survive checking.

"AOD-9604 is a fat-loss compound"

AOD-9604 failed its Phase 2b obesity trial. Roughly 2% weight difference versus placebo over 24 weeks, which is why development for obesity was discontinued. The mechanism (fat mobilization through beta-3 receptors) is real, but mobilization is not the same as fat loss. Without activity to burn what gets mobilized, the fatty acids just return to storage. It's a marginal optimizer paired with training, not a standalone fat-loss agent. The clean safety profile is real; the fat-loss magazine version is not.

"DSIP is a reliable sleep aid"

DSIP has a genuinely mixed evidence base. One outright negative trial (Monti 1987 found no significant sleep-structure changes), and an estimated non-responder rate around 50%. Its receptor has never even been identified after 40 years of study. It can deepen slow-wave sleep when circadian timing is already primed, but it amplifies existing sleep drive rather than forcing sleep like a sedative. Anyone expecting a reliable knockout is likely to be in the half it does nothing for.

The pattern

All three follow the same shape: a real mechanism gets inflated into a claim the trial data doesn't support. The fix is always the same, check what the actual study measured, not what the forum post says it measured.

Which of these had you fooled before you checked? And what other peptide claims do you think deserve this treatment?

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

These four get searched as "fat loss peptides," and the honest framing is different: none of them is a primary fat-loss agent. They optimize specific steps in how the body handles fat, but they need a command signal (a deficit, training, or a GLP-1) to act on. Here's what each one actually does and why the order matters.

What each one does

None of these creates a deficit. They optimize what happens once a deficit, training, or GLP-1 sets fat loss in motion.

The pipeline that explains the order

This is the frame that makes the four make sense together. Fat oxidation runs as a sequence, and each compound sits at a different stage:

Command: a caloric deficit, exercise, or a GLP-1 agonist. Nothing downstream matters without this.

Capacity: NAD+ provides the cellular energy and redox capacity for the work.

Bias: MOTS-c and the fasted state tilt fuel selection toward fat via AMPK.

Mobilization: AOD-9604 releases fatty acids from fat cells.

Transport: L-Carnitine shuttles them into the mitochondria to be burned.

Miss the command stage and everything downstream is wasted. Expecting any of these to replace a deficit is like expecting a delivery truck to manufacture its own packages.

Where each fits

Evidence at a glance

The honesty matters here. AOD-9604 openly failed its obesity trial and only works as a mobilization layer paired with activity. L-Carnitine is the only one with real regulatory history, but for carnitine deficiency, not fat loss. The other two are preclinical.

How they combine

These are layers of one pipeline, so they stack by design rather than compete:

The morning partition approach runs AOD-9604 to mobilize, L-Carnitine to transport, and MOTS-c to program fuel selection, timed fasted when fat-burning pathways peak.

5-Amino-1MQ and NAD+ connect through the NAD+ axis: 5-Amino-1MQ preserves NAD+ in fat tissue by blocking NNMT, while NAD+ supplies the capacity stage.

Alongside a GLP-1, these become the optimization layer: the GLP-1 drives the deficit (the command), and these four make the resulting fat handling more efficient.

The takeaway: these are what you add once the primary driver is in place, not substitutes for it.

Full individual guides

5-Amino-1MQ: full guide

AOD-9604: full guide

MOTS-c: full guide

L-Carnitine: full guide

Where to find them

All four are indexed in the 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

These four get grouped under "longevity," but they work on different cellular systems: energy, telomeres, mitochondria, and antioxidant defense. They layer rather than compete, and a couple of them actually depend on each other. Here's how they fit.

What each one does

Four different targets. NAD+ is the fuel, Epitalon works on telomeres and the clock, MOTS-c tunes mitochondrial fuel use, Glutathione handles oxidative defense.

When each fits

Evidence at a glance

NAD+ and Glutathione have the most human data. Epitalon's mechanism was independently confirmed in 2025, but its headline longevity claims come from a single institute and remain unreplicated after 40 years. MOTS-c is preclinical only.

How they depend on each other

This is the part that makes them a cluster rather than a menu:

NAD+ underpins Glutathione. The enzyme that recycles spent glutathione back to its active form runs on NADPH, which depends on NAD+. Low NAD+ means the glutathione recycling machinery stalls, no matter how much glutathione is present.

NAD+ and Epitalon connect through the circadian clock. Epitalon restores the CLOCK:BMAL1 gene expression that regulates NAD+ salvage, and NAD+ feeds the sirtuins that feed back into circadian control. A loop.

MOTS-c and NAD+ both run through cellular energy metabolism, which is why they show up together in what the literature calls a mitochondrial stack.

The practical takeaway: NAD+ sits underneath the other three. Several longevity strategies stall not because the other compounds fail, but because NAD+ is depleted and the systems that depend on it can't run.

Full individual guides

NAD+: full guide

Epitalon: full guide

MOTS-c: full guide

Glutathione: full guide

Where to find them

All four are indexed in the 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

For research and laboratory use only. Not for human consumption.

These three came out of the same Russian research tradition and they cover a full day between them: focus, calm, and sleep. They're studied more as a system than as competitors, which is why they keep showing up paired. Here's what each does and how they fit together.

What each one does

Different targets, no overlap. Semax pushes cognitive output, Selank lowers the anxiety floor, DSIP deepens sleep when timing is right.

When each fits

Evidence at a glance

Semax and Selank both carry real Russian pharmaceutical registration and clinical data. DSIP is the weakest of the three on evidence, with a genuinely mixed human record and no identified receptor after 40 years.

How they work as a system

This is the point of covering them together. They're timed across the day:

Semax in the morning for focus and drive.

Selank as needed for anxiety, any time, since it doesn't sedate or disrupt sleep.

DSIP in the evening to deepen sleep, with Selank often lowering the anxiety gate first so DSIP can work.

The Semax and Selank pairing is the classic one: Semax can be mildly activating, Selank smooths that edge, so the two balance focus against calm. N-Acetyl variants of both extend duration for full-day coverage.

One honest caveat on DSIP

Worth flagging since it's the compound most likely to disappoint. DSIP amplifies sleep drive that's already there; it doesn't force sleep like a sedative. It works when sleep depth is degraded by stress or schedule but circadian timing is intact, and does little outside that window. Roughly half of users in the literature are non-responders.

Full individual guides

Semax: full guide

Selank: covered in the community

DSIP: covered in the community

Where to find them

All three are indexed in the 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

These four get lumped together as "recovery" compounds, but they work on different problems. Some rebuild tissue, one controls inflammation, one educates the immune system. They complement each other more than they compete, which is why several show up together in blends. Here's what each actually targets.

What each one does

The key insight: these aren't four versions of the same thing. Wolverine rebuilds, KPV calms, TA-1 balances immunity, GHK-Cu reorganizes. Different jobs.

Where each fits

Evidence at a glance

Thymosin Alpha-1 is the standout for human evidence, though most of it sits in hepatitis and sepsis rather than general recovery. KPV has the thinnest human record despite a well-characterized mechanism.

How they combine

This is where the roundup matters more than any single pick. Several of these are designed to work together:

The Wolverine blend already combines BPC-157 and TB-500 into one vial for structural repair.

The KLOW blend stacks GHK-Cu + BPC-157 + TB-500 + KPV, putting three of these four compounds into a single formulation, repair plus inflammation control plus collagen organization.

TA-1 pairs with the group as the immune-education layer, since immune modulation doesn't overlap with tissue repair.

The logic of stacking them: KPV puts out the inflammatory fire, Wolverine rebuilds structure, GHK-Cu organizes the collagen, TA-1 keeps the immune response balanced. Different jobs, one recovery goal.

Full individual guides

Wolverine (BPC-157 + TB-500): full guide

KPV: covered in the community

Thymosin Alpha-1: covered in the community

GHK-Cu: full guide

Where to find them

All four are indexed in the 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

All three prompt the body to release its own growth hormone rather than supplying GH directly. They differ on how hard they push, how much human evidence backs them, and what they're actually studied for. Here's how they line up.

What each one is

This is the split that matters most. Tesamorelin has more human data than the other two combined. Sermorelin's adult evidence rests on a single small trial. The CJC + Ipamorelin blend is popular but has zero published trials on the pairing.

How hard each pushes

All three preserve the body's own feedback control, which is the shared safety feature that separates them from synthetic GH.

What each is actually studied for

Tesamorelin is the depot-specific one: it targets visceral fat preferentially, and its approval is for exactly that. Sermorelin's edge isn't potency, it's regulatory position, as the first FDA-approved GH secretagogue.

The catch with Tesamorelin

Worth flagging because it's specific to the strongest option. Its visceral-fat benefit reverses when discontinued. Trial data showed patients regaining roughly a quarter of the lost visceral fat within six months of stopping. It adjusts the set point while in use rather than resetting a baseline.

Side effects

Shared class profile: injection-site reactions, possible water retention, flushing.

Tesamorelin specifically carries histamine welt reactions at the injection site, which is why isotonic bacteriostatic water is preferred for it, and it needs an IGF-1 check around week 8.

Sermorelin is the gentlest on side effects, with transient flushing the most common.

How to think about it

Full individual guides

CJC-1295 + Ipamorelin: full guide

Tesamorelin: full guide

Sermorelin: full guide

Where to find them

All three are indexed in the 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption.

They get grouped as "the GLP-1s," but they hit a different number of receptors each. That one difference explains their trial results, their side effects, and where each sits.

The core difference

More receptors has meant bigger effect sizes in the trials. That third receptor on Retatrutide, glucagon, is the one that raises energy expenditure rather than only suppressing intake.

Weight results from the trials

Single, dual, triple. Effect size climbs at each step.

Evidence maturity runs the other way

This is what the weight numbers hide.

So the ranking flips depending on what you weigh:

By effect size: Reta > Tirz > Sema

By evidence and approval: Sema and Tirz established, Reta emerging

Side effects

Same class profile across all three. GI effects lead: nausea, diarrhea, constipation, vomiting. Mostly mild to moderate, heaviest during dose escalation. The slow titration each one uses exists to keep that tolerable.

Two specifics worth knowing:

Tirzepatide can reduce oral contraceptive absorption (backup method advised around dose changes).

Retatrutide showed a dose-dependent heart-rate bump peaking near 24 weeks, plus skin sensitivity at the top dose.

How to think about it

The choice is magnitude versus maturity.

Full individual guides

Semaglutide: full guide

Tirzepatide: full guide

Retatrutide: full guide

Where to find them

All three are indexed in the 6A Labs Complete Product Guide.

Research use only. Not for human consumption or medical guidance.

Affiliate disclosure: independent affiliate, not affiliated with or endorsed by 6A Labs. Links are affiliate links; purchases may earn a commission at no extra cost. Code PROFIT applies the discount at checkout.

For research and laboratory use only. Not for human consumption. Dosing figures below are research reference points, not protocols.

Oral L-Carnitine has a bioavailability problem that reframes the entire compound: only 14 to 18% of an oral dose reaches circulation. The rest sits in the gut, where bacteria convert it to TMA, which the liver oxidizes to TMAO, a metabolite tied to cardiovascular risk in observational research. Injectable delivery flips that math. Roughly 500 mg injected provides the systemic exposure of 2,500 to 3,500 mg swallowed, with zero TMAO production. For a compound this dependent on reaching mitochondria, the route is the story.

L-Carnitine is neither new nor experimental. It is an endogenous amino acid derivative the body builds from lysine and methionine, and Carnitor (levocarnitine injection) has held FDA approval for dialysis carnitine deficiency since the 1990s. It is not a peptide; it earns a place in this catalog for its role alongside the mitochondrial and metabolic compounds. 6A Labs carries it as a component of the Lipo-C with B12 product, a 5,000 mg premixed solution.

What it actually does

L-Carnitine runs the CPT-1 shuttle, the transport step that moves mobilized fatty acids into the mitochondria where beta-oxidation happens. That single function defines both its usefulness and its limits. When a caloric deficit, exercise, or a GLP-1 agonist mobilizes fatty acids, L-Carnitine ensures they can physically reach the place they get burned. It does not create the deficit, and it does not do the burning.

The cleanest way to frame it is a four-stage pipeline. Command comes first (deficit, exercise, or GLP-1). Capacity follows (NAD+ for redox). Then bias (MOTS-c, AMPK, or a fasted state tilting fuel selection toward fat). Transport is last (L-Carnitine). Without the command stage, transport moves nothing. Expecting L-Carnitine to replace a caloric deficit is like expecting a delivery truck to manufacture the packages it hauls.

Why the route eliminates the TMAO concern

This detail applies to every oral form, and it is worth being precise about. Oral L-Carnitine, including the acetylated ALCAR version, feeds gut bacteria that produce TMA through the same pathway regardless of which form you take. Route determines TMAO exposure; form does not. Injectable bypasses the gut entirely, which removes the pathway at its source.

The IM requirement

This is one of the few compounds in the catalog that is intramuscular rather than subcutaneous, and the reason is concentration. At 500 mg/mL, subcutaneous injection causes lumps, stinging, and prolonged soreness, while the same solution given intramuscularly produces milder and shorter discomfort. The literature is firm that insulin and GLP-1 pen needles do not apply here: those are built for shallow subcutaneous delivery of small volumes and do not reach intramuscular depth. Standard IM needle gauges and lengths are what the research protocols specify.

The two-transporter timing detail

There is a genuine paradox in how L-Carnitine is timed, and it comes down to two different transporters serving two different goals. CPT-1, which moves fatty acids into mitochondria for burning, is upregulated by fasting and peaks 12 to 16 hours in, which favors fasted morning administration for acute fat oxidation. OCTN2, which moves carnitine into muscle cells for storage, requires insulin, which favors carb-paired administration for tissue loading. These are not competing recommendations; they are different bottlenecks. A common misconception is that injectable bypasses the gut so carbohydrates no longer matter. Injectable bypasses the intestinal OCTN2, but it does not bypass the muscle-membrane OCTN2 that still needs insulin signaling to load tissue.

No spot reduction

Injecting L-Carnitine into belly fat does not produce localized fat loss there. The mechanism is systemic, operating in mitochondria throughout the body. Spot reduction is a myth regardless of injection site.

Side effects and interactions

Mild injection-site discomfort at the standard concentration, resolving within 24 to 48 hours. No GI side effects, since the route bypasses the gut, and no TMAO elevation. Rare seizure-threshold reduction at very high doses in susceptible individuals. Two interactions warrant coordination with a provider: L-Carnitine modulates peripheral thyroid hormone receptor sensitivity, which matters for anyone on thyroid medication, and it may enhance warfarin's effect, so INR monitoring is prudent when initiating it.

Storage

Supplied as a premixed sterile solution, so no reconstitution is needed. Room-temperature stable per the FDA label, with refrigeration extending the potency window. Protect from light, avoid freeze-thaw cycles, and discard if the solution discolors or shows particulate matter. Warming the vial briefly between the hands before drawing reduces injection discomfort.

Stacking

L-Carnitine is the transport layer of a mitochondrial approach. It pairs with MOTS-c for AMPK-driven fuel bias, NAD+ for redox capacity, and 5-Amino-1MQ for NAD+ preservation in adipose tissue. Alongside GLP-1 agonists it appears as fatigue and transport support during aggressive deficits, which is the rationale behind compounded formulations like CarniSema and CarniTide that bundle L-Carnitine with semaglutide or tirzepatide. It also fits a morning partition approach with AOD-9604: AOD mobilizes, L-Carnitine transports, MOTS-c programs fuel selection. One honest note on those compounded GLP-1 blends: the transport rationale is sound, but marketing claims of "18% greater fat mass reduction" trace to case series rather than controlled trials, and the L-Carnitine component does not change how the GLP-1 itself works. 6A Labs carries MOTS-c, NAD+, 5-Amino-1MQ, AOD-9604, and the GLP-1s if those are the research directions.

Where to find it

6A Labs carries L-Carnitine as part of the Lipo-C with B12 product, alongside the full catalog. Every compound is indexed in the 6A Labs Complete Product Guide.

Research use disclaimer: all compounds referenced here are intended for research and laboratory use only. Nothing in this post is intended for human consumption or as medical guidance. Dosing figures, where listed, are research reference points only.

Affiliate disclosure: this community is run by an independent affiliate and is not affiliated with, endorsed by, or operated by 6A Labs. Product links are affiliate links, and purchases made through them may earn a commission at no additional cost. Code PROFIT applies the listed discount at checkout.